Krebs Biochemicals and Industries Limited approved Re-constitution of Audit Committee: With the above changes in the Board Composition, the Audit Committee of the Company is re-constitute with effect from 10th August, 2023 is as under: Mr. GVL Prasad - Non-Executive & Independent Director /Chairman of the Committee, Mr. Satish Khivsara - Non-Executive & Independent Director, Dr. Malati Tangirala - Non-Executive & Independent Director, Mr. Jitendra Shah Managing Director & CEO.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
72.6 INR | +0.71% |
|
+0.35% | -7.33% |
1st Jan change | Capi. | |
---|---|---|
-7.33% | 1.86Cr | |
+16.80% | 4.33TCr | |
+17.47% | 2.16TCr | |
+21.54% | 1.59TCr | |
+23.95% | 1.51TCr | |
+57.96% | 1.3TCr | |
-0.05% | 678.76Cr | |
-16.22% | 629.03Cr | |
+19.77% | 603.62Cr | |
-8.87% | 572.55Cr |
- Stock Market
- Equities
- KREBSBIO Stock
- News Krebs Biochemicals & Industries Limited
- Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023